A randomised phase III cross-over study of tamoxifen versus megestrol acetate in advanced and recurrent breast cancer

European Journal of Cancer Part A

Volumn 32, Issue 11, 1996, Pages 1888-1892

  Stuart, N S A ^a,e   Warwick, J ^a   Blackledge, G R P ^a   Spooner, D ^a   Keen, C ^b   Taylor, A R ^c   Tyrell, C ^d   Webster, D J T ^b   Earl, H ^f  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b VELINDRE CANCER CENTRE   (United Kingdom)

^c STOKE MANDEVILLE HOSPITAL   (United Kingdom)

^d Freedom Fields Hospital   (United Kingdom)

^e YSBYTY GWYNEDD   (United Kingdom)

^f NONE

Author keywords

Breast cancer; Megestrol acetate; Postmenopausal; Randomised study; Tamoxifen

Indexed keywords

MEGESTROL ACETATE; TAMOXIFEN; TAMOXIFEN CITRATE;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RECURRENCE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; EDEMA; FEMALE; HOT FLUSH; HUMAN; HYPERGLYCEMIA; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MENOPAUSE; MULTICENTER STUDY; NAUSEA; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEDATION; VAGINA BLEEDING; WEIGHT GAIN;

EID: 0030272671     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/0959-8049(96)00191-8     Document Type: Article

References (10)

1. 1. Rose C, Mouridsen HT. Endocrine therapy of advanced breast cancer. Acta Oncol 1988, 27, 721-728.
2. 2. Willemse PH, van Ploeg dPE, Sleijfer DT, Tjabbes T. A randomized comparison of megestrol acetate (NMA) and medroxyprogesterone acetate (NMPA) in patients with advanced breast cancer. Eur Cancer 1990, 26, 337-343.
3. 3. Gregory EJ, Cohen SC, Oines DW. Megestrol acetate therapy for advanced breast cancer. J Clin Oncol 1985, 3, 155-160.
4. 4. Lundgren S. Progestins in breast cancer treatment. A review. Acta Oncologica 1992, 31, 709-722.
5. 5. Kalbfleisch JD, Prentice FL. The Statistical Analysis of Failure Time Data. New York, John Wiley & Son, 1980.
6. 2 tests. Biometrics 1954, 10, 417-420.
7. 7. Ingle JN, Cregan ET, Ahmann DL, et al. Randomized clinical trials of megestrol acetate versus tamoxifen in paramenopausal or castrated women with advanced breast cancer. Am J Clin Oncol 1982, 5, 155-160.
8. 8. Morgan L. Megestrol acetate v tamoxifen in advanced breast cancer in postmenopausal patients. Semin Oncol 1985, 12, 43-47.
9. 9. Muss HB, Pascold EH, Black WR, et al. Megestrol acetate v tamoxifen in advanced breast cancer: a Phase III trial of the Pidmont Oncology Association (POA). Semin Oncol 1985, 12 (Suppl. 1), 55-61.
10. 10. Paterson AHG, Hanson J, Pritchard KI, et al. Comparison of antiestrogen and progestogen therapy for initial treatment and consequences of their combination for second-line treatment of breast cancer. Semin Oncol 1990, 17 (Suppl. 9), 52-62.